Olivier V.
- Country
- France
- Department
- Rheumatology
Research Overview
- Comparison of Bimekizumab versus Adalimumab for the Treatment of Anterior Chest Wall Pain in Patients with Active Axial Spondyloarthritis Refractory to NSAIDs
- Evaluation of Dose Tapering Versus Continuation of JAK Inhibitors Baricitinib, Upadacitinib, Tofacitinib, and Filgotinib in Low Disease Activity Rheumatoid Arthritis
- A Randomized, Open-Label, Superiority Trial Comparing Subcutaneous Abatacept and Tocilizumab in Rheumatoid Arthritis Patients with Inadequate Response to Targeted Therapies
Data & Insights
Has run more than one trial at 25 of 154 partner sites.
Specializations
Rheumatoid Arthritis Management
Specializes in evaluating advanced therapeutic approaches for rheumatoid arthritis, particularly focusing on biological treatments and targeted therapies.
- Comparative efficacy of subcutaneous biologics
- Maintenance treatment optimization
- JAK inhibitor dosing strategies
Investigates treatment responses in patients with inadequate response to conventional therapies.
Spondyloarthritis Research
Conducts research in the treatment of axial spondyloarthritis, exploring innovative therapeutic approaches using targeted medications.
- Novel therapeutic agents
- Signs and symptoms management
- Treatment efficacy assessment
Focuses on evaluating advanced treatment options for inflammatory spinal conditions.
Gout Therapeutics
Explores optimal treatment timing and strategies for gout management, with particular interest in hypouricemic therapy.
- Acute attack intervention
- Treatment timing optimization
- Long-term disease management
Investigates innovative approaches to acute gout attack treatment and prevention.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.